
Researchers from Tel Aviv University and the Israel Institute for Biological Research have developed an mRNA-based vaccine found to be 100 percent effective against a deadly type of bacteria when tested in lab animals.
According to the researchers, their new technology can enable rapid development of effective vaccines for bacterial diseases, including diseases caused by antibiotic-resistant bacteria.